Come up with a name for your new list and we'll add to it:
Argenes raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
Argenes, Inc. is a Japanese bio-venture established in April 2004 focusing primarily on the development of biopharmaceuticals and molecular targeting therapeutics, including anti-rheumatoid arthritis …